Mechanistically, our work indicates that combination treatment with CpG and RT enhances the activation and proliferation of intratumoral CD8+ T cells, as demonstrated by CyTOF, IHC, scRNA-Seq, and bulk tumor RNA-Seq. The gene discussed is CD8A; the disease is neoplasm.